Your browser doesn't support javascript.
loading
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆.
Casali, P G; Le Cesne, A; Velasco, A P; Kotasek, D; Rutkowski, P; Hohenberger, P; Fumagalli, E; Judson, I R; Italiano, A; Gelderblom, H; Penel, N; Hartmann, J T; Duffaud, F; Goldstein, D; Martin-Broto, J; Gronchi, A; Wardelmann, E; Marréaud, S; Zalcberg, J R; Litière, S; Blay, J-Y.
Afiliação
  • Casali PG; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy; Gustave Roussy, Villejuif, France. Electronic address: paolo.casali@istitutotumori.mi.it.
  • Le Cesne A; Instituto Valenciano De Oncologia, Valencia, Spain.
  • Velasco AP; Adelaide Cancer Centre, Kurralta Park, and Division of Medicine, University of Adelaide, Australia.
  • Kotasek D; Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
  • Rutkowski P; Mannheim University Medical Center, Mannheim, Germany.
  • Hohenberger P; Royal Marsden Hospital, London, UK.
  • Fumagalli E; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy; Gustave Roussy, Villejuif, France.
  • Judson IR; Institut Bergonie, Bordeaux, France.
  • Italiano A; Institut Bergonie, Bordeaux, France.
  • Gelderblom H; Leiden University Medical Center, Leiden, Netherlands.
  • Penel N; Centre Oscar Lambret, Lille, France.
  • Hartmann JT; Medizinische Universitätsklinik II, Tübingen, Germany.
  • Duffaud F; Hôpital de La Timone, Aix-Marseille Université, Marseille, France.
  • Goldstein D; Prince of Wales Hospital, Sydney, Australia.
  • Martin-Broto J; Hospital Universitari Son Espases, Palma de Mallorca, Spain.
  • Gronchi A; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy.
  • Wardelmann E; University Hospital Münster, Münster, Germany.
  • Marréaud S; EORTC Headquarters, Brussels, Belgium.
  • Zalcberg JR; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Litière S; EORTC Headquarters, Brussels, Belgium.
  • Blay JY; Department of Medicine, NetSARC and LYRIC, Centre Leon Berard, Lyon, France.
Ann Oncol ; 32(4): 533-541, 2021 04.
Article em En | MEDLINE | ID: mdl-33482247

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Tumores do Estroma Gastrointestinal / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Tumores do Estroma Gastrointestinal / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article